Literature DB >> 17239900

Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII.

Sabine Huke1, Donald M Bers.   

Abstract

Frequency-dependent acceleration of relaxation (FDAR) is an important intrinsic mechanism that allows for diastolic filling of the ventricle at higher heart rates, yet its molecular mechanism is still not understood. Previous studies showed that FDAR is dependent on functional sarcoplasmic reticulum (SR) and can be abolished by phosphatase or by Ca/CaM kinase (CaMKII) inhibition. Additionally, CaMKII activity/autophosphorylation has been shown to be frequency-dependent. Thus, we tested the hypothesis that CaMKII phosphorylation of SR Ca(2+)-handling proteins (Phospholamban (PLB), Ca(2+) release channel (RyR)) mediates FDAR. Here we show that FDAR occurs abruptly in fluo-4 loaded isolated rat ventricular myocytes when frequency is raised from 0.1 to 2 Hz. The effect is essentially complete within four beats (2 s) with the tau of [Ca(2+)](i) decline decreasing by 42+/-3%. While there is a detectable increase in PLB Thr-17 and RyR Ser-2814 phosphorylation, the increase is quantitatively small (PLB<5%, RyR approximately 8%) and the time-course is clearly delayed with regard to FDAR. The low substrate phosphorylation indicates that pacing of myocytes only mildly activates CaMKII and consistent with this CaMKIIdelta autophosphorylation did not increase with pacing alone. However, in the presence of phosphatase 1 inhibition pacing triggered a net-increase in autophosphorylated CaMKII and also greatly enhanced PLB and RyR phosphorylation. We conclude that FDAR does not rely on phosphorylation of PLB or RyR. Even though CaMKII does become activated when myocytes are paced, phosphatases immediately antagonize CaMKII action, limit substrate phosphorylation and also prevent sustained CaMKII autophosphorylation (thereby suppressing global CaMKII effects).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17239900      PMCID: PMC1857340          DOI: 10.1016/j.yjmcc.2006.12.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  46 in total

1.  Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A.

Authors:  Patricia Rodriguez; Moninder S Bhogal; John Colyer
Journal:  J Biol Chem       Date:  2003-10-03       Impact factor: 5.157

2.  Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart.

Authors:  Susan Currie; Christopher M Loughrey; Margaret-Anne Craig; Godfrey L Smith
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 3.  Analysing cardiac excitation-contraction coupling with mathematical models of local control.

Authors:  Christian Soeller; Mark B Cannell
Journal:  Prog Biophys Mol Biol       Date:  2004 Jun-Jul       Impact factor: 3.667

4.  Phosphorylation-status of phospholamban and calsequestrin modifies their affinity towards commonly used antibodies.

Authors:  Sabine Huke; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2004-09       Impact factor: 5.000

5.  The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.

Authors:  Tong Zhang; Lars S Maier; Nancy D Dalton; Shigeki Miyamoto; John Ross; Donald M Bers; Joan Heller Brown
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

6.  The role of autophosphorylation in activation of the type II calmodulin-dependent protein kinase.

Authors:  A P Kwiatkowski; D J Shell; M M King
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

7.  CaMKII inhibition targeted to the sarcoplasmic reticulum inhibits frequency-dependent acceleration of relaxation and Ca2+ current facilitation.

Authors:  Eckard Picht; Jaime DeSantiago; Sabine Huke; Marcia A Kaetzel; John R Dedman; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2006-10-17       Impact factor: 5.000

8.  Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban.

Authors:  L K MacDougall; L R Jones; P Cohen
Journal:  Eur J Biochem       Date:  1991-03-28

9.  Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility.

Authors:  Wen Zhao; Yoshiki Uehara; Guoxiang Chu; Qiujing Song; Jiang Qian; Karen Young; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2004-08       Impact factor: 5.000

10.  Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven R Reiken; Andrew R Marks
Journal:  Circ Res       Date:  2004-03-11       Impact factor: 17.367

View more
  45 in total

1.  Synergy between CaMKII substrates and β-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling.

Authors:  Anthony R Soltis; Jeffrey J Saucerman
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  Phospholemman is a negative feed-forward regulator of Ca2+ in β-adrenergic signaling, accelerating β-adrenergic inotropy.

Authors:  Jason H Yang; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2012-01-20       Impact factor: 5.000

3.  SR-targeted CaMKII inhibition improves SR Ca²+ handling, but accelerates cardiac remodeling in mice overexpressing CaMKIIδC.

Authors:  Sabine Huke; Jaime Desantiago; Marcia A Kaetzel; Shikha Mishra; Joan H Brown; John R Dedman; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2010-10-21       Impact factor: 5.000

Review 4.  Determinants of frequency-dependent contraction and relaxation of mammalian myocardium.

Authors:  Paul M L Janssen; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2007-08-28       Impact factor: 5.000

5.  CaMKII-induced shift in modal gating explains L-type Ca(2+) current facilitation: a modeling study.

Authors:  Yasmin L Hashambhoy; Raimond L Winslow; Joseph L Greenstein
Journal:  Biophys J       Date:  2009-03-04       Impact factor: 4.033

6.  Role of activated CaMKII in abnormal calcium homeostasis and I(Na) remodeling after myocardial infarction: insights from mathematical modeling.

Authors:  Thomas J Hund; Keith F Decker; Evelyn Kanter; Peter J Mohler; Penelope A Boyden; Richard B Schuessler; Kathryn A Yamada; Yoram Rudy
Journal:  J Mol Cell Cardiol       Date:  2008-06-28       Impact factor: 5.000

7.  The calcium-frequency response in the rat ventricular myocyte: an experimental and modelling study.

Authors:  Sara Gattoni; Åsmund Treu Røe; Michael Frisk; William E Louch; Steven A Niederer; Nicolas P Smith
Journal:  J Physiol       Date:  2016-06-26       Impact factor: 5.182

8.  A random cycle length approach for assessment of myocardial contraction in isolated rabbit myocardium.

Authors:  Kenneth D Varian; Ying Xu; Carlos A A Torres; Michelle M Monasky; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-11       Impact factor: 4.733

9.  Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.

Authors:  Miriam Kalbitz; Fatemeh Fattahi; Todd J Herron; Jamison J Grailer; Lawrence Jajou; Hope Lu; Markus Huber-Lang; Firas S Zetoune; J Vidya Sarma; Sharlene M Day; Mark W Russell; José Jalife; Peter A Ward
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

10.  Mechanistic Investigation of the Arrhythmogenic Role of Oxidized CaMKII in the Heart.

Authors:  Panagiota T Foteinou; Joseph L Greenstein; Raimond L Winslow
Journal:  Biophys J       Date:  2015-08-18       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.